Julieta Abraham-Miranda

Immunologic disparities in prostate cancer between American men of African and European descent.

K. Yamoah, S. Awasthi, Julieta Abraham-Miranda, 2021, Critical reviews in oncology/hematology.

CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production

R. Atkins, J. Kańska, F. Locke, 2022, Frontiers in Immunology.

Enhanced dissolution profiles of glibenclamide with amino acids using a cogrinding method

M. Longhi, A. Zoppi, Julieta Abraham-Miranda, 2021 .

Evaluating ternary systems with oligosaccharides as a strategy to improve the biopharmaceutical properties of furosemide.

A. Ayala, C. Garnero, A. K. Chattah, 2020, Materials science & engineering. C, Materials for biological applications.

Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer

Joshua D. Campbell, B. Trock, T. Rebbeck, 2020, Clinical Cancer Research.

Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer

R. Gillies, R. Gatenby, Min Liu, 2021, Cancer Research.

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis

J. Torres-Roca, D. Hunt, K. Latifi, 2020, Prostate Cancer and Prostatic Diseases.

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis

J. Pow-Sang, J. Torres-Roca, D. Hunt, 2020, Prostate Cancer and Prostatic Diseases.

Investigating a Soluble Pharmaceutical Salt: Albendazole Hydrochloride

A. Ayala, C. Garnero, A. K. Chattah, 2019, Crystal Growth & Design.

Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer.

T. Rebbeck, J. Pow-Sang, J. Torres-Roca, 2020, European urology.